Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 1 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Lucase3 L C currently has 2 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are assigned to 2 distinct examiners but are both contained within 1 distinct art unit. This structure suggests that the company's pending technology is concentrated in 1 administrative department, even though multiple examiners are reviewing the work.
The busiest examiner for the portfolio is MILLER-CRUZ, EKANDRA S., who is handling 1 busiest examiner pending action. This is 1 of the 2 pending office actions for the company. The presence of 2 distinct examiners requires the company to manage 2 different sets of feedback and procedural expectations within the same 1 distinct art unit.
The focus on Biotechnology & Pharmaceuticals indicates a specialized patenting effort. With 2 pending office actions total, the company's prosecution pipeline is currently small. However, the use of 2 distinct examiners within 1 distinct art unit means that the company must be prepared for potentially different interpretations of the same technical field or prior art.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (50%) |
| §112 only | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MILLER-CRUZ, EKANDRA S. | 1 | 65.8% | +51.9% |
| MONSHIPOURI, MARYAM | 1 | 79.1% | +37.5% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18734118 | SYSTEM AND METHOD FOR STARTCH SEPARATION AND DRY FRACTURING WITH FIBER WASH | MILLER-CRUZ, EKANDRA S. | — |
| 18223346 | HIGH VALUE PROTEIN PRODUCTION FROM WASTE ORGANIC STREAMS AT AN EXISTING ETHANOL PLANT | MONSHIPOURI, MARYAM | — |
| Art Unit | Apps |
|---|---|
| 1651 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18734118 | SYSTEM AND METHOD FOR STARTCH SEPARATION AND DRY FRACTURING WITH FIBER WASH | MILLER-CRUZ, EKANDRA S. | — | §103Other | Non-Final OA | — | Pending | Jun 05, 2024 |
| 18223346 | HIGH VALUE PROTEIN PRODUCTION FROM WASTE ORGANIC STREAMS AT AN EXISTING ETHANOL PLANT | MONSHIPOURI, MARYAM | 1651 | §112 | Final Rejection | — | Pending | Jul 18, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial